Barclays Downgrades Qiagen to Equal-Weight, Announces $44 Price Target
Benzinga Newsdesk 7 months ago
NewsDowngradesPrice TargetAnalyst Ratings
Barclays analyst Luke Sergott downgrades Qiagen (NYSE:QGEN) from Overweight to Equal-Weight and announces $44 price target.
Barclays analyst Luke Sergott downgrades Qiagen (NYSE:QGEN) from Overweight to Equal-Weight and announces $44 price target.